| Schedule of Convertible Note and Warrant Liabilities |
| | |
Convertible
note | | |
Warrant
liabilities | |
| | |
$ | | |
$ | |
| | |
| | |
| |
| Balance as of December 31, 2025 | |
| - | | |
| 1,213,340 | |
| Gain on derecognition of warrants repurchased | |
| - | | |
| (355,857 | ) |
| Repurchase of warrant liabilities | |
| - | | |
| (857,143 | ) |
| Issued on March 2, 2026, at fair value | |
| 10,573,648 | | |
| 6,544,124 | |
| Fair value changes | |
| (2,640,885 | ) | |
| (4,303,563 | ) |
| Gain on derecognition of convertible notes on cash settlement | |
| (151,071 | ) | |
| | |
| Gain recognised in other comprehensive income – own credit risk | |
| (1,726 | ) | |
| - | |
| Settlement in cash | |
| (5,784,573 | ) | |
| - | |
| Converted or exercised into Class A ordinary shares | |
| (667,528 | ) | |
| (2,223,168 | ) |
| As of June 30, 2026 – fair value | |
| 1,327,865 | | |
| 17,733 | |
| Day 1 difference not yet recognized in profit or loss | |
| (1,313,486 | ) | |
| - | |
| Balance as of June 30, 2026 (unaudited) | |
| 14,379 | | |
| 17,733 | |
| | |
| | | |
| | |
| Day 1 difference not yet recognized in profit or loss | |
| | | |
| | |
| Balance as of December 31, 2025 | |
| - | | |
| - | |
| Deferred on initial recognition, March 2, 2026 | |
| 7,176,298 | | |
| 4,441,474 | |
| Amortization of deferred day-one loss from the redemption of the convertible notes | |
| (5,065,446 | ) | |
| - | |
| Amortization of deferred day-one loss the settlement of the convertible notes | |
| (344,317 | ) | |
| - | |
Amortization against the share capital credit on the conversion of the convertible notes | |
| (453,049 | ) | |
| (1,508,856 | ) |
| Amortization of deferred day-one loss on the warrants exercises | |
| - | | |
| (2,932,618 | ) |
| Balance as of June 30, 2026 (unaudited) | |
| 1,313,486 | | |
| - | |
|
| Schedule of Fair Value Measurements Within Level 3 |
Significant unobservable inputs included
expected volatility, expected term, risk-free interest rate, discount rate and assumptions regarding redemption and settlement outcomes.
Because these inputs are not directly observable in active markets and involve significant management judgment, the related fair value
measurements were classified within Level 3 of the fair value hierarchy under IFRS 13.
| | | | | As of June 30, 2026 | | | As of June 2, 2026 | | | As of April 13, 2026 | | | As of March 13, 2026 | | | As of March 12, 2026 | | | As of March 4, 2026 | | | As of March 2, 2026* | | | Valuation Technique | | Significant Unobservable Input | | | | | | | | | | | | | | | | | | | | | | | Black-Scholes option pricing model | | Expected volatility | | | 86.1 | % | | | - | | | | 83.2 | % | | | 82.1 | % | | | 81.6 | % | | | 81.4 | % | | | 81.1 | % | | | | Expected term (years) | | | 4.67 | | | | - | | | | 4.89 | | | | 4.97 | | | | 4.97 | | | | 4.99 | | | | 5.00 | | | | | Risk-free interest rate | | | 4.2 | % | | | - | | | | 3.9 | % | | | 3.9 | % | | | 3.9 | % | | | 3.7 | % | | | 3.6 | % | | Discounted cash flow methodology | | Discounted rate | | | 16.6 | % | | | 15.1 | % | | | - | | | | - | | | | - | | | | - | | | | 14.7 | % |
| * | March 2, 2026 represents the initial measurement date. The
fair value of the instruments was determined upon issuance using the valuation techniques and significant unobservable inputs disclosed
above. Subsequent fair value measurements were performed at each conversion date and as of June 30, 2026. |
|